These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35920945)

  • 41. Incidence and Predictors of Angiographic Vasospasm, Symptomatic Vasospasm and Cerebral Infarction in Chinese Patients with Aneurysmal Subarachnoid Hemorrhage.
    Mijiti M; Mijiti P; Axier A; Amuti M; Guohua Z; Xiaojiang C; Kadeer K; Xixian W; Geng D; Maimaitili A
    PLoS One; 2016; 11(12):e0168657. PubMed ID: 27977801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcranial-Doppler-Measured Vasospasm Severity is Associated with Delayed Cerebral Infarction After Subarachnoid Hemorrhage.
    Snider SB; Migdady I; LaRose SL; Mckeown ME; Regenhardt RW; Lai PMR; Vaitkevicius H; Du R
    Neurocrit Care; 2022 Jun; 36(3):815-821. PubMed ID: 34751900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial.
    Senbokuya N; Kinouchi H; Kanemaru K; Ohashi Y; Fukamachi A; Yagi S; Shimizu T; Furuya K; Uchida M; Takeuchi N; Nakano S; Koizumi H; Kobayashi C; Fukasawa I; Takahashi T; Kuroda K; Nishiyama Y; Yoshioka H; Horikoshi T
    J Neurosurg; 2013 Jan; 118(1):121-30. PubMed ID: 23039152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beta-blocker therapy and impact on outcome after aneurysmal subarachnoid hemorrhage: a cohort study.
    Chalouhi N; Daou B; Okabe T; Starke RM; Dalyai R; Bovenzi CD; Anderson EC; Barros G; Reese A; Jabbour P; Tjoumakaris S; Rosenwasser R; Kraft WK; Rincon F
    J Neurosurg; 2016 Sep; 125(3):730-6. PubMed ID: 26799296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thick and Diffuse Subarachnoid Blood as a Treatment Effect Modifier of Clazosentan After Subarachnoid Hemorrhage.
    Mayer SA; Aldrich EF; Bruder N; Hmissi A; Macdonald RL; Viarasilpa T; Marr A; Roux S; Higashida RT
    Stroke; 2019 Oct; 50(10):2738-2744. PubMed ID: 31394993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage.
    Yahia AM; Kirmani JF; Qureshi AI; Guterman LR; Hopkins LN
    Neurocrit Care; 2005; 3(1):16-23. PubMed ID: 16159090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial.
    Tseng MY; Czosnyka M; Richards H; Pickard JD; Kirkpatrick PJ
    Stroke; 2005 Aug; 36(8):1627-32. PubMed ID: 16049199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can interhemispheric desynchronization of cerebral blood flow anticipate upcoming vasospasm in aneurysmal subarachnoid haemorrhage patients?
    Placek MM; Smielewski P; Wachel P; Budohoski KP; Czosnyka M; Kasprowicz M
    J Neurosci Methods; 2019 Sep; 325():108358. PubMed ID: 31306719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage with Asymptomatic Angiographic Vasospasm on Admission.
    Aldakkan A; Mansouri A; Jaja BN; Alotaibi NM; Macdonald RL;
    World Neurosurg; 2017 Jan; 97():199-204. PubMed ID: 27717776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spinal cord stimulation and early experimental cerebral spasm: the "functional monitoring" and the "preventing effect".
    Visocchi M; Argiolas L; Meglio M; Cioni B; Basso PD; Rollo M; Cabezas D
    Acta Neurochir (Wien); 2001; 143(2):177-85. PubMed ID: 11459092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dual antiplatelet therapy does not improve outcomes after aneurysmal subarachnoid hemorrhage compared with aspirin monotherapy.
    Wallace AN; Kayan Y; Almandoz JED; Mulder M; Milner AA; Scholz JM; Stiernagle K; Contestabile E; Tipps ME
    Clin Neurol Neurosurg; 2020 Aug; 195():106038. PubMed ID: 32650208
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrocardiographic changes predict angiographic vasospasm after aneurysmal subarachnoid hemorrhage.
    Ibrahim GM; Macdonald RL
    Stroke; 2012 Aug; 43(8):2102-7. PubMed ID: 22678087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia.
    Nagahama Y; Allan L; Nakagawa D; Zanaty M; Starke RM; Chalouhi N; Jabbour P; Brown RD; Derdeyn CP; Leira EC; Broderick J; Chimowitz M; Torner JC; Hasan D
    J Neurosurg; 2018 Sep; 129(3):702-710. PubMed ID: 29099296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early Hemodynamic Changes Based on Initial Color-Coding Angiography as a Predictor for Developing Subsequent Symptomatic Vasospasm After Aneurysmal Subarachnoid Hemorrhage.
    Burkhardt JK; Chen X; Winkler EA; Weiss M; Yue JK; Cooke DL; Kim H; Lawton MT
    World Neurosurg; 2018 Jan; 109():e363-e373. PubMed ID: 28987853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cocaine use is an independent risk factor for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Conway JE; Tamargo RJ
    Stroke; 2001 Oct; 32(10):2338-43. PubMed ID: 11588323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Length of hospital stay in aneurysmal subarachnoid hemorrhage patients without vasospasm on angiography: potential for a fast-track discharge cohort.
    Catapano JS; Srinivasan VM; Rumalla K; Labib MA; Nguyen CL; Cole TS; Baranoski JF; Rutledge C; Rahmani R; Lawton MT; Ducruet AF; Albuquerque FC
    J Neurointerv Surg; 2022 Apr; 14(4):376-379. PubMed ID: 34078646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperoxemia and Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage.
    Reynolds RA; Amin SN; Jonathan SV; Tang AR; Lan M; Wang C; Bastarache JA; Ware LB; Thompson RC
    Neurocrit Care; 2021 Aug; 35(1):30-38. PubMed ID: 33150573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of remote ischemic preconditioning on cerebral oxygen saturation in aneurysmal subarachnoid hemorrhage: Secondary analysis of a randomized controlled trial.
    Sangeetha RP; Ramesh VJ; Kamath S; Chakrabarti D; Christopher R; Aravinda HR; Bhat DI
    J Clin Neurosci; 2022 Apr; 98():78-82. PubMed ID: 35134661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute hydrocephalus and delayed cerebral infarction after aneurysmal subarachnoid hemorrhage.
    Masson A; Boulouis G; Janot K; Herbreteau D; Cottier JP; Bibi R; Cohen C; Obry S; Velut S; Amelot A; Ifergan H
    Acta Neurochir (Wien); 2022 Sep; 164(9):2401-2408. PubMed ID: 35918615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.